Disclosures for "Tear Fluid as a Biomarker for Parkinson’s Disease: Downregulation of DNA Repair Genes/Pathways via RNA-Seq Analysis")
-
Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for adamas. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH.
-
Miss Omidsalar has nothing to disclose.
-
Miss Singh Kakan has nothing to disclose.
-
Mr. Gerke has nothing to disclose.
-
Ms. Tanveer has nothing to disclose.
-
Dr. Feigenbaum has nothing to disclose.
-
Dr. Tamadonfar has nothing to disclose.
-
Sarah Hamm-Alvarez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oyster Point. The institution of Sarah Hamm-Alvarez has received research support from Oyster Point.
-
Dr. Hjelm has nothing to disclose.